Introduction
The concussion is the most common mild traumatic brain injury (mTBI) seen in contact sports, usually resulting from minor trauma to the head [1] [2] . It is a transient neurologic deficit often associated with impairment of consciousness. Minor symptoms can include a headache, dizziness, light sensitivity, abnormal gait, nausea or vomiting. The abnormality may not be observable in the routine neurological examination; even standard neuroimaging diagnostics, such as computerized tomography (CT) and magnetic resonance imaging (MRI) may reveal no abnormality. Therefore, diagnosis is often based on the appearance and severity of the aforementioned minor symptoms.
In sports-related concussion, diagnosis is even more challenging due to factors such as underreporting, underrecognition, and unwitnessed events combined with various psychosocial issues, e.g. peer pressure, apprehension over mandatory game rest or even economic concerns like potential salary loss or educational scholarship revocation. Repeated concussive events without allowing adequate 'brain rest' is the most common cause of persistent symptoms lasting more than three months, commonly termed post-concussion syndrome. Effects may be long-term and debilitating, including poor school performance and inability to maintain normal physical activity.
Maruta [3] takes up the challenge of operationalizing brain injury, successfully correlating mTBI with impaired performance on a smooth pursuit eye test. It was previously shown that strength of visual attention is associated with the same areas of the brain that are damaged in concussion [4] [5] . Maruta's research shows that predictive timing and essential element of attention is very often impaired in individuals with mTBI. sensory processing and motor execution of goal-oriented behavior. In 13 concussed and 127 normal subjects between the ages of 18 to 55 years, DVS scores of subjects with mild head injury were worse than 95% of those without the concussion. Also, longitudinal monitoring of injured subjects revealed that their DVS scores improved toward the normal range as they healed. The scores were reproducible with little learning effect.
In detail, the test involved, asking subjects to follow a target stimulus moving clockwise in a circular trajectory with a 10° radius at 0.4 hertz (Hz). DVS was characterized by the variability of the instantaneous gaze positional error in the direction parallel to the target movement. In other words, more variability between the velocity of the target and the subject's eye movement resulted in a higher (worse) DVS score. The focus is a 10-second test for impaired brain function. Focus can be used immediately after the injury including that on the sidelines during competition. A test subject looks at a small white circle moving in a figure-eight pattern against a black background on a tablet screen. The EyeGuide eye tracking headset records their eye movements during the test. Deviation from expected gaze position during the test (in partial pixels, at 60 Hz) is totaled to yield a test score (the lower is better).
Before the season begins, the athlete takes one test, called the baseline. Then, if an injury is suspected, he or she takes the same test again. The system compares the athlete's score with his or her baseline score as well as the scores of thousands of other, similar athletes in the system. If the score is abnormally high, it would indicate a drop in neurocognitive ability associated with brain injury.
The value of such a test, if effective, would mean fast, low-cost mTBI assessment, especially in sports athletes and could be made available as another reliable tool for athletic trainers and other healthcare professionals tasked with recognizing and managing concussions.
This technical report details the results of an uncontrolled study of EyeGuide Focus which attempted to determine the efficacy of Focus as an impairment measurement instrument using the same DVS analytical method employed by Maruta.
Technical Report
The Focus hardware (EyeGuide, Lubbock, Texas, United States) consists of a head-mounted eye tracking device and a standard 9.7-inch iPad. The iPad runs EyeGuide's proprietary Focus app, which provides roster management and neurological impairment testing capabilities. The eye tracking hardware communicates with the software running on the iPad over Wi-Fi.
In the EyeGuide Focus test, the stimulus (a white filled circle against a black background) starts at the center of the tablet screen and moves clockwise through one cycle of a "lazy 8" path. In other words, starting from the center of the display, the stimulus follows the path of a circle, clockwise around an invisible point in the center-right of the display. When the stimulus reaches the center of the display again, the path changes to a counterclockwise circle around an invisible point in the center-left of the display. Finally, when the stimulus returns to the center of the display again, it begins again to track the right circular path. The test ends after exactly 10 seconds after the stimulus has begun again to track the right circular path. Each test including the normative, individual baseline test is assigned a score. To determine the score, the input data points (pupil center coordinates, 60 per second) are first transformed to negate any effect of the athlete having observed the stimulus at an oblique angle. In other words, the points at the extremes of the test are used as guide points to transform all of the points to the coordinate system of the original stimulus on the tablet display screen. This post-test coordinate transformation also eliminates the need for a discrete pre-test calibration step, which further reduces the time taken to complete the test and prevents possible "gaming" of the test by athletes who might purposely perform poorly during calibration.
Then, the final test score is taken to be the sum of the distances between the transformed pupil center coordinates and the actual on-screen stimulus coordinates for the entire duration of the test, that saved the first and last seconds. Thus, a score of zero would indicate flawless performance through the entire operational duration of the test, while higher scores indicate worse performance. There is no upper bound on test scores. Though it might seem that zero would be the lower bound, in practice no athlete can achieve a perfect score.
Focus test scores from 849 athletes of ages 12-18 years with 46.4% female and 53.6% male were collected in spring 2015. Descriptive statistics are given in Table 1 
TABLE 1: Descriptives of focus normative data
The raw Focus score data were transformed based on z-score computation, with a mean = 50 and a standard deviation = 10. Computed T-scores were compared to immediate post-concussion assessment and cognitive testing (ImPACT) normative scores [6] and classification ranges were established from "mildly impaired" to "very superior" (see Table 2 ), with the majority of respondents falling into the "average" range of T-score equal to 44 to 56.99 (original n=366). Additionally, the Focus software was modified to shift these category parameters automatically with each addition to the baseline population.
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FIGURE 2: Focus test result shows impaired score
Because Focus is cloud-based, all new, uploaded Focus scores from athletes are used to update the threshold parameters so that they are current and reflective of the entire community of the tested athletes.
With more data, it is hoped that an "impaired" score in Focus can be correlated directly with a concussion. However, at present Focus is not designated as a medical device and cannot be used to detect concussion. But still, a feature in its software allows for test administrators to mark an impaired score with a "C" label for the concussion. This labeling is only done after a physician diagnoses concussion and the purpose is to establish an injury snapshot in Focus so that future testing after injury can be used along with other tools available to the test administrator to manage the return of the athlete to normal and thus dectect the eligibility for participation again in sports.
Discussion
Now deployed at multiple locations across the United States, Focus, to date, has recorded more than 4,000 test scores. Of these, 2,736 have been designated as individual baseline scores. Two hundred and twenty-seven have been labeled as impaired. Ninty eight have been labeled with a "C", indicating as noted before, that a physician has diagnosed the athlete in question with a concussion and the test administrator has marked an impaired score with "C" to signal a recovery monitoring start point.
Specifically, there are 42 instances of athletes recording an individual baseline test followed then by a severely impaired score that was later labeled as a concussed score. The analysis shows a statistical significance association between the baseline and concussed scores (see Figure 3 ). 
Conclusions
We performed a preliminary statistical analysis on data from a few thousand subjects to gauge the efficacy of EyeGuide Focus, a low-cost, ocular-based impairment test for assessing concussion. A comparison of all baseline scores (n=2736) to all concussion scores (n=98) found a T-test P-value < 0.001, indicating a significant difference in means between the two.
Additionally, there were 42 instances of athletes recording an individual baseline test followed by a severely impaired score that was later labeled as a concussed score. Analysis showed a statistical significance association between the baseline and concussed scores. Further, 17 athletes with individual and impaired concussed scores also had follow-up test scores indicating a return to the same threshold as the prior, pre-injury baseline score, demonstrating that Focus has the potential to track healthy return to normal in athletes.
Currently, independent researchers are managing more controlled studies to evaluate the efficacy of Focus among particular populations and sports.
